Contract Win
December 12 2011 - 2:00AM
RNS Non-Regulatory
TIDMIMTK
Imaginatik PLC
12 December 2011
12 December 2011
Imaginatik plc
("Imaginatik" or the "Company")
Contract Win
Imaginatik plc (AIM: IMTK), a leading provider of enterprise
innovation solutions including a range of technology products and
consultancy, is pleased to announce it has signed a consultancy
contract with a US based global leader in paediatric nutrition to
enhance its innovation capabilities. No financial details have been
disclosed.
This is a full service agreement whereby Imaginatik will assist
the client in designing and implementing a complete, end-to-end
innovation programme at the enterprise level. Imaginatik will
support the client in developing an innovation process through the
provision of its technology platform, Discovery Suite, in
combination with innovation consultancy. In addition, Imaginatik
will provide training to help the client build a core innovation
team which will ensure a sustainable solution and repeatable
process for innovation.
Matt Cooper, Executive Chairman of Imaginatik, commented, "This
new contract is a strong endorsement of the evolution of the
Imaginatik strategy towards providing end-to-end innovation
programmes. We believe Imaginatik now occupies a unique position in
its market as the only company with the proven ability to support
sustainable enterprise innovation programmes through a combination
of technology, consultancy and repeatable processes."
For further information please contact:
Imaginatik plc Tel: 020 7917
2975
Matt Cooper, Executive Chairman / Shawn
Taylor, CFO
Northland Capital Partners Limited Tel: 020 7796
8800
Gavin Burnell / Edward Hutton
Threadneedle Communications Tel: 020 7653
9850
Caroline Evans-Jones / Hilary Millar
About Imaginatik
Imaginatik provides Innovation and Idea management solutions
comprised of consultancy, enterprise software and program
management to deliver innovation results to companies such as The
World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing,
Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies
possess the internal capability to consistently generate fresh
ideas, identify those worth pursuing and reliably transform them
into real, value-enhancing assets. This is Imaginatik's area of
expertise.
Imaginatik is a public company whose shares are traded on the
AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World
Economic Forum Technology Pioneer with offices in Boston, MA, and
Winchester, UK. For more information visit www.imaginatik.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRABRBDDGDGBGBC
Abal (LSE:ABAL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Abal (LSE:ABAL)
Historical Stock Chart
From Jul 2023 to Jul 2024